K. L. Monzón

Synergistic potentiation of the anti-metastatic effect of anti EGFR mAb by its combination with immunotherapies targeting the ganglioside NGcGM3

V. Segatori, M. Gabri, Addys González Palomo, 2018, Oncotarget.

Harmonization of Epidermal Growth Factor Measurements: Paving the Way of Finding A Biomarker in Non-Small Cell Lung Cancer

K. L. Monzón, Idania González-Pérez, 2016 .

Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it’s potential therapeutic implications

M. Gabri, X. Perez, Addys González Palomo, 2016, Clinical & Experimental Metastasis.

SARS-CoV-2 RBD-Tetanus toxoid conjugate vaccine induces a strong neutralizing immunity in preclinical studies

R. Oliva, Guang-Wu Chen, L. González, 2021, bioRxiv.

A quantitative approach to dominant tolerance

K. L. Monzón, 2002 .

Dose‐response study for the highly aggressive and metastatic primary F3II mammary carcinoma under direct current

J. I. Montijano, L. Cabrales, M. V. Jarque, 2018, Bioelectromagnetics.

Efficacy of direct current generated by multiple-electrode arrays on F3II mammary carcinoma: experiment and mathematical modeling

J. I. Montijano, L. Cabrales, M. M. González, 2020, Journal of Translational Medicine.